SEC Form 4 · accession 0001144204-17-053025
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sol J Barer
Director
Period of report
Oct 17, 2017
Accepted (ET)
Oct 18, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 17, 2017 | P | 421,032 | $1.26 | A | 1,028,032 | D | |
| Common StockF1 | holding | — | — | — | 153,846 | I | By: Wife | |
| Common StockF2 | holding | — | — | — | 365,854 | I | By: grantor retained annuity trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy) | $2.84 | Oct 17, 2017 | P | 74,912 | A | Oct 17, 2017 | Oct 17, 2022 | Common Stock | 74,912 | 74,912 | D |
Explanation of responses
- F1Shares purchased by the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F2By the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV.